• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对人脑-肠肽胆囊收缩素受体的结构洞察。

Structural insights into human brain-gut peptide cholecystokinin receptors.

作者信息

Ding Yu, Zhang Huibing, Liao Yu-Ying, Chen Li-Nan, Ji Su-Yu, Qin Jiao, Mao Chunyou, Shen Dan-Dan, Lin Lin, Wang Hao, Zhang Yan, Li Xiao-Ming

机构信息

Department of Neurobiology and Department of Neurology of Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

NHC and CAMS Key Laboratory of Medical Neurobiology, MOE Frontier Center of Brain Science and Brain-machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

出版信息

Cell Discov. 2022 Jun 7;8(1):55. doi: 10.1038/s41421-022-00420-3.

DOI:10.1038/s41421-022-00420-3
PMID:35672283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9174195/
Abstract

The intestinal hormone and neuromodulator cholecystokinin (CCK) receptors CCK1R and CCK2R act as a signaling hub in brain-gut axis, mediating digestion, emotion, and memory regulation. CCK receptors exhibit distinct preferences for ligands in different posttranslational modification (PTM) states. CCK1R couples to G and G, whereas CCK2R primarily couples to G. Here we report the cryo-electron microscopy (cryo-EM) structures of CCK1R-G signaling complexes liganded either by sulfated cholecystokinin octapeptide (CCK-8) or a CCK1R-selective small-molecule SR146131, and CCK2R-G complexes stabilized by either sulfated CCK-8 or a CCK2R-selective ligand gastrin-17. Our structures reveal a location-conserved yet charge-distinct pocket discriminating the effects of ligand PTM states on receptor subtype preference, the unique pocket topology underlying selectivity of SR146131 and gastrin-17, the conformational changes in receptor activation, and key residues contributing to G protein subtype specificity, providing multiple structural templates for drug design targeting the brain-gut axis.

摘要

肠道激素和神经调节剂胆囊收缩素(CCK)的受体CCK1R和CCK2R在脑-肠轴中作为信号枢纽,介导消化、情绪和记忆调节。CCK受体对处于不同翻译后修饰(PTM)状态的配体表现出不同的偏好。CCK1R与G和G偶联,而CCK2R主要与G偶联。在此,我们报告了由硫酸化胆囊收缩素八肽(CCK-8)或CCK1R选择性小分子SR146131配体的CCK1R-G信号复合物以及由硫酸化CCK-8或CCK2R选择性配体胃泌素-17稳定的CCK2R-G复合物的冷冻电子显微镜(cryo-EM)结构。我们的结构揭示了一个位置保守但电荷不同的口袋,该口袋区分配体PTM状态对受体亚型偏好的影响、SR146131和胃泌素-17选择性的独特口袋拓扑结构、受体激活中的构象变化以及对G蛋白亚型特异性有贡献的关键残基,为靶向脑-肠轴的药物设计提供了多个结构模板。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/980efeb3db93/41421_2022_420_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/f391f69d8ca2/41421_2022_420_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/172310324a33/41421_2022_420_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/af0387099792/41421_2022_420_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/4b133e46ff92/41421_2022_420_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/d8beecbbce6c/41421_2022_420_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/c0f06f769f35/41421_2022_420_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/980efeb3db93/41421_2022_420_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/f391f69d8ca2/41421_2022_420_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/172310324a33/41421_2022_420_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/af0387099792/41421_2022_420_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/4b133e46ff92/41421_2022_420_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/d8beecbbce6c/41421_2022_420_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/c0f06f769f35/41421_2022_420_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78e/9174195/980efeb3db93/41421_2022_420_Fig7_HTML.jpg

相似文献

1
Structural insights into human brain-gut peptide cholecystokinin receptors.对人脑-肠肽胆囊收缩素受体的结构洞察。
Cell Discov. 2022 Jun 7;8(1):55. doi: 10.1038/s41421-022-00420-3.
2
Structures of the human cholecystokinin 1 (CCK1) receptor bound to Gs and Gq mimetic proteins provide insight into mechanisms of G protein selectivity.人类胆囊收缩素 1(CCK1)受体与 Gs 和 Gq 模拟蛋白结合的结构为 G 蛋白选择性机制提供了深入了解。
PLoS Biol. 2021 Jun 4;19(6):e3001295. doi: 10.1371/journal.pbio.3001295. eCollection 2021 Jun.
3
Molecular and functional characterization of cionin receptors in the ascidian, Ciona intestinalis: the evolutionary origin of the vertebrate cholecystokinin/gastrin family.腔肠动物海鞘中 cionin 受体的分子和功能特征:脊椎动物胆囊收缩素/胃泌素家族的进化起源。
J Endocrinol. 2012 Apr;213(1):99-106. doi: 10.1530/JOE-11-0410. Epub 2012 Jan 30.
4
Molecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor.胆囊收缩素受体 1,4-苯二氮䓬拮抗剂配体结合和亚型选择性的分子基础。
J Biol Chem. 2012 May 25;287(22):18618-35. doi: 10.1074/jbc.M111.335646. Epub 2012 Mar 30.
5
Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.开发具有治疗潜力的胆囊收缩素(CCK)/胃泌素受体配体的进展。
Curr Opin Pharmacol. 2007 Dec;7(6):583-92. doi: 10.1016/j.coph.2007.09.011. Epub 2007 Nov 9.
6
Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies.通过分子建模、定点诱变和结构/亲和力研究,鉴定胆囊收缩素2受体的酪氨酸189和天冬酰胺358与胆囊收缩素关键的C末端酰胺直接相互作用。
Mol Pharmacol. 2003 May;63(5):973-82. doi: 10.1124/mol.63.5.973.
7
Up-regulation of cholesterol absorption is a mechanism for cholecystokinin-induced hypercholesterolemia.胆固醇吸收的上调是胆囊收缩素引起高胆固醇血症的机制。
J Biol Chem. 2014 May 9;289(19):12989-99. doi: 10.1074/jbc.M113.534388. Epub 2014 Apr 1.
8
Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding.开发一种高选择性的胆囊收缩素受体 1 变构拮抗剂放射性配体及其结合的分子基础。
Mol Pharmacol. 2015 Jan;87(1):130-40. doi: 10.1124/mol.114.095430. Epub 2014 Oct 15.
9
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.SR146131:一种新型强效、口服活性且选择性的非肽类胆囊收缩素1型受体激动剂。I. 体外研究。
J Pharmacol Exp Ther. 1999 May;289(2):742-51.
10
The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process.胆囊收缩素具有生物学重要性的C末端与非肽类激动剂SR-146,131在人CCK1受体中共享一个共同的结合位点。Met-121在激活过程中起关键作用的证据。
J Biol Chem. 2002 Mar 1;277(9):7546-55. doi: 10.1074/jbc.M108563200. Epub 2001 Nov 27.

引用本文的文献

1
The central signaling pathways related to metabolism-regulating hormones of the gut-brain axis: a review.肠道-脑轴中与代谢调节激素相关的中枢信号通路:综述
J Transl Med. 2025 Jun 11;23(1):648. doi: 10.1186/s12967-025-06656-3.
2
Cross-talk between microbiota-gut-brain axis and blood pressure regulation.微生物群-肠道-脑轴与血压调节之间的相互作用。
Clin Sci (Lond). 2025 May 8;139(9):431-47. doi: 10.1042/CS20240787.
3
A disturbed communication between hypothalamic-pituitary-ovary axis and gut microbiota in female infertility: is diet to blame?

本文引用的文献

1
Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes.DRD1-Gs 信号复合物的配体识别和变构调节。
Cell. 2021 Feb 18;184(4):943-956.e18. doi: 10.1016/j.cell.2021.01.028. Epub 2021 Feb 10.
2
Structural insights into the human D1 and D2 dopamine receptor signaling complexes.解析人类 D1 和 D2 多巴胺受体信号复合物的结构。
Cell. 2021 Feb 18;184(4):931-942.e18. doi: 10.1016/j.cell.2021.01.027. Epub 2021 Feb 10.
3
Structures of the human dopamine D3 receptor-G complexes.人源多巴胺 D3 受体-G 复合物结构。
女性不孕症中下丘脑-垂体-卵巢轴与肠道微生物群之间的通讯紊乱:是饮食的错吗?
J Transl Med. 2025 Jan 21;23(1):92. doi: 10.1186/s12967-025-06117-x.
4
Neuropeptide cholecystokinin: a key neuromodulator for hippocampal functions.神经肽胆囊收缩素:海马体功能的关键神经调节剂。
Neural Regen Res. 2025 Jul 1;20(7):1991-1992. doi: 10.4103/NRR.NRR-D-24-00465. Epub 2024 Jul 10.
5
Structural basis of tethered agonism and G protein coupling of protease-activated receptors.蛋白酶激活受体的束缚激动和 G 蛋白偶联的结构基础。
Cell Res. 2024 Oct;34(10):725-734. doi: 10.1038/s41422-024-00997-2. Epub 2024 Jul 12.
6
A Novel CCK Receptor GPR173 Mediates Potentiation of GABAergic Inhibition.一种新型胆囊收缩素受体 GPR173 介导 GABA 能抑制的增效作用。
J Neurosci. 2023 Mar 29;43(13):2305-2325. doi: 10.1523/JNEUROSCI.2035-22.2023. Epub 2023 Feb 22.
7
Elucidating the molecular determinants in the process of gastrin C-terminal pentapeptide amide end activating cholecystokinin 2 receptor by Gaussian accelerated molecular dynamics simulations.通过高斯加速分子动力学模拟阐明胃泌素C末端五肽酰胺激活胆囊收缩素2受体过程中的分子决定因素。
Front Pharmacol. 2023 Jan 23;13:1054575. doi: 10.3389/fphar.2022.1054575. eCollection 2022.
Mol Cell. 2021 Mar 18;81(6):1147-1159.e4. doi: 10.1016/j.molcel.2021.01.003. Epub 2021 Feb 5.
4
Cryo-EM structure of an activated VIP1 receptor-G protein complex revealed by a NanoBiT tethering strategy.冷冻电镜结构解析揭示 VIP1 受体-G 蛋白复合物的激活状态 通过 NanoBiT 连接策略。
Nat Commun. 2020 Aug 17;11(1):4121. doi: 10.1038/s41467-020-17933-8.
5
Structural basis of GPBAR activation and bile acid recognition.GPBAR 激活和胆汁酸识别的结构基础。
Nature. 2020 Nov;587(7834):499-504. doi: 10.1038/s41586-020-2569-1. Epub 2020 Jul 22.
6
An allosteric modulator binds to a conformational hub in the β adrenergic receptor.变构调节剂与β肾上腺素受体中的构象枢纽结合。
Nat Chem Biol. 2020 Jul;16(7):749-755. doi: 10.1038/s41589-020-0549-2. Epub 2020 Jun 1.
7
Rules of Engagement: GPCRs and G Proteins.作用机制:G蛋白偶联受体与G蛋白
ACS Pharmacol Transl Sci. 2018 Sep 7;1(2):73-83. doi: 10.1021/acsptsci.8b00026. eCollection 2018 Nov 9.
8
Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes.胃泌素、胆囊收缩素、信号传导及细胞过程中的生物学活性
Front Endocrinol (Lausanne). 2020 Mar 6;11:112. doi: 10.3389/fendo.2020.00112. eCollection 2020.
9
Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G Complex Structures.大麻素受体-G 复合物结构揭示的激活和信号转导机制。
Cell. 2020 Feb 20;180(4):655-665.e18. doi: 10.1016/j.cell.2020.01.008. Epub 2020 Jan 30.
10
Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.阻断胆囊收缩素 CCK-2 受体可防止大鼠焦虑水平正常化。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109761. doi: 10.1016/j.pnpbp.2019.109761. Epub 2019 Sep 14.